Compare CDNA & NABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | NABL |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 945.6M |
| IPO Year | 2007 | 2021 |
| Metric | CDNA | NABL |
|---|---|---|
| Price | $20.03 | $3.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $28.00 | $8.31 |
| AVG Volume (30 Days) | 733.8K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $48,324,000.00 | ★ $511,430,000.00 |
| Revenue This Year | $16.01 | $11.04 |
| Revenue Next Year | $11.31 | $8.53 |
| P/E Ratio | $409.60 | ★ N/A |
| Revenue Growth | ★ 18.93 | 9.71 |
| 52 Week Low | $10.96 | $3.32 |
| 52 Week High | $23.24 | $9.04 |
| Indicator | CDNA | NABL |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 25.47 |
| Support Level | $16.63 | N/A |
| Resistance Level | $21.20 | $5.22 |
| Average True Range (ATR) | 1.33 | 0.33 |
| MACD | -0.22 | -0.23 |
| Stochastic Oscillator | 38.34 | 7.34 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.